| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.76B | 29.92B | 27.07B | 26.44B | 24.60B | 19.55B |
| Gross Profit | 17.28B | 15.95B | 8.42B | 17.04B | 16.14B | 5.38B |
| EBITDA | 7.27B | 6.17B | 5.79B | 6.37B | 5.86B | 4.86B |
| Net Income | 1.34B | 695.12M | 1.28B | 1.16B | 1.15B | 675.11M |
Balance Sheet | ||||||
| Total Assets | 109.84B | 113.85B | 106.14B | 98.46B | 93.17B | 88.46B |
| Cash, Cash Equivalents and Short-Term Investments | 8.43B | 7.69B | 10.00B | 9.42B | 7.60B | 7.15B |
| Total Debt | 34.81B | 38.29B | 31.31B | 27.38B | 26.23B | 25.67B |
| Total Liabilities | 102.45B | 106.01B | 98.26B | 93.13B | 89.19B | 85.86B |
| Stockholders Equity | 7.32B | 7.78B | 7.80B | 5.24B | 3.90B | 2.50B |
Cash Flow | ||||||
| Free Cash Flow | 311.38M | 848.29M | 2.95B | 2.87B | 4.20B | 3.66B |
| Operating Cash Flow | 2.58B | 5.05B | 6.21B | 6.24B | 6.81B | 4.98B |
| Investing Cash Flow | -1.45B | -2.38B | -4.01B | -4.49B | -2.10B | -2.57B |
| Financing Cash Flow | -1.31B | -2.65B | -2.85B | -1.90B | -4.59B | -2.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹19.60B | 13.46 | ― | 0.98% | -1.09% | 16.30% | |
73 Outperform | ₹17.36B | 21.58 | ― | 0.48% | 12.31% | 73.06% | |
65 Neutral | ₹18.91B | 18.32 | ― | 0.48% | 7.70% | 23.63% | |
62 Neutral | ₹46.35B | 44.72 | ― | 0.50% | 10.28% | 10.17% | |
62 Neutral | ₹25.51B | 29.66 | ― | 0.36% | 14.30% | 6.51% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
47 Neutral | ₹46.42B | 27.42 | ― | ― | 7.58% | -45.54% |